Retraction notice to “Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases” [Eur. J. Med. Chem. 190 (2020) 112074] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300416), (10.1016/j.ejmech.2020.112074))

Jiann Fong Lee, Ting Yu Chang, Zheng Fang Liu, Nian Zhe Lee, Yen Hsiu Yeh, Yi Song Chen, Tsung Chih Chen, Hao Syun Chou, Tsai Kun Li, Sung Bau Lee, Mei Hsiang Lin

Research output: Contribution to journalComment/debate

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the authors. The authors regret to inform that they would like to withdraw this accepted article, due to serious errors in authorship, affiliations, material sources and supporting grant names/numbers. The authors sincerely apologize for these oversights and miscommunications the study caused.

Original languageEnglish
Article number112490
JournalEuropean Journal of Medicinal Chemistry
Volume199
DOIs
Publication statusPublished - Aug 1 2020

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Retraction notice to “Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases” [Eur. J. Med. Chem. 190 (2020) 112074] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300416), (10.1016/j.ejmech.2020.112074))'. Together they form a unique fingerprint.

  • Cite this